Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Cenkos Securities Plc LSE:CNKS London Ordinary Share GB00B1FLHR07 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.0% 47.00 46.00 48.00 47.00 47.00 47.00 21,800 08:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
General Financial 25.9 0.1 -0.2 - 27

Cenkos Securities Share Discussion Threads

Showing 3551 to 3572 of 3725 messages
Chat Pages: 149  148  147  146  145  144  143  142  141  140  139  138  Older
DateSubjectAuthorDiscuss
18/2/2020
09:08
Could be significant operational hearing here - on the upside - with costs pared right back
albert zog
18/2/2020
08:57
Do non-execs make much difference. Always seemed to be a cosy club for boosting their pensions when in retirement. Strong, positive update: augurs well for an upturn in fortunes in 2020 and from a very solid state on the balance sheet.
trident5
18/2/2020
08:51
Odd choice of Chairman though. What relevant investment bank experience has she got versus the previous board members? Trading update positive.
topvest
18/2/2020
08:44
Board Change - HTTPS://www.investegate.co.uk/cenkos-securities--cnks-/rns/board-change/202002180701022708D/ The Board of Cenkos is pleased to announce, that following a thorough external search process, it has appointed Lisa Gordon, as an Independent Non-Executive Director and to the position of Chairman. This appointment is subject to Financial Conduct Authority approval and will take effect once regulatory approval has been received. Lisa has more than 25 years of Board experience, in both Executive and Non-Executive roles at both listed and private companies. Lisa is a Non-Executive Director of Alpha FX Group plc an AIM listed corporate foreign exchange specialist and she chairs their Remuneration and Audit Committees. She is also the Non-Executive Chairman of Albert Technologies Limited, an artificial intelligence technology business and a Non-Executive Director of Magic Light Pictures Limited, a leading film and television production company. Lisa has held a number of Senior and Board positions. She was a founding Director and the Corporate Development Director of Local World plc (prior to its acquisition by Trinity Mirror) (2012-2015); the Chief Operating Officer of Yattendon Group (2007-2013), a private conglomerate; and the Director of Corporate Development of Chrysalis Group PLC, the media group (1994-2004). Prior to this Lisa's early background was in financial services as an analyst with Greig Middleton and County NatWest Securities (1988-1993). Lisa will be appointed as the Chairman of the Company's Nomination Committee and will also be a member of the Audit, Risk and Compliance Committee, as well as the Remuneration Committee. More on the new Chairman here - HTTPS://www.alphafx.co.uk/about/people/lisa-gordon/group/leadership-team/
speedsgh
18/2/2020
08:18
Pretty much a confirmation by the CEO that a final dividend will be paid. The recent interim divi declared in September 2019 was 2p. Taking an educated guess that final dividend will be the same as last year at 2.5p, Cenkos is now trading at a prospective yield of some 7% at a share price of 65p. Of course, the final divi may be higher than 2.5p. Combined with a very buoyant outlook indeed, this is beginning to look very encouraging again and a clear sign that the sector has rapidly become much more favourable. The grave uncertainty which had shrouded the market for so long due to Brexit has lifted and the pent-up demand for M&A, IPO's and cash-raisings for business investment is now coming on stream fast. An excellent update. In my view, there is significant upside in the short and medium-term for the sector, for Cenkos, and for the share price. ALL IMO. DYOR. QP
quepassa
14/2/2020
20:42
Yes, looks like they are starting to get the show on the road. Lets hope that they can get a jumbo deal away in the Spring / Summer like the old days!
topvest
14/2/2020
09:28
Excellent news. Another lucrative IPO for Cenkos announced - and we are only in early February. Public deals in last couple of months £52million Placing/open Offer Creo Medival £120m Buchan 2 Sole Adviser to Buyer £31m IPO MJ Hudson IPO FRP Advisory £30m IPO Very buoyant and strong start to 2020. ALL IMO. DYOR. QP
quepassa
14/2/2020
09:03
Insolvency firm FRP Advisory appoints broker for London float - HTTPS://www.cityam.com/insolvency-firm-frp-advisory-appoints-broker-for-london-float/ Insolvency firm FRP Advisory has appointed broker Cenkos Securities for an upcoming London listing. The insolvency practitioner, which also advises clients on corporate finance matters, is planning to raise £30m in a float that will value it at £200m...
speedsgh
12/2/2020
21:29
2020 is hopefully going to be a better year for Cenkos.
topvest
12/2/2020
18:14
Just some figures. At the back end of 2019, Cenkos carried out a successful Placing + Open Offer in December for £51.9million for Creo Medical. If the maximum amount of £56.6million had been raised, the Net Proceeds to Creo would have been £53.7million. Meaning that fees/expenses of £2.9million would have been payable by Creo out of gross proceeds, being a percentage of fees/expenses of 5.12% of amounts raised. In the event, a very healthy £51.9m was raised. Using the same fee structure of 5.12%, this means that fees of some £2,657,280 would have been payable. By far the largest chunk of these fees/expenses would have been payable to Cenkos. A great way to end the 2019 year. Just as Score Group/ Buchan 2 is a great way to start 2020 with a sole Adviser mandate for £120 million. Added to the upbeat statements given by conference sponsor Cenkos yesterday, things are beginning to look very encouraging again with some big fees already being scored under the aegis and return of the rainmaker Founding CEO. ALL IMO. DYOR. QP ps - haven't done the math but of course Cenkos would also have earned handsomely in the December IPO of MJ Hudson for £31.4million as well.
quepassa
12/2/2020
17:22
Brokerage fees are rarely more than 3%, partic of 2ndry share placings. Not shabby but not as lucrative as you think
albert zog
12/2/2020
16:20
Just some figures. At the back end of 2019, Cenkos carried out a successful Placing + Open Offer in December for £51.9million for Creo Medical. If the maximum amount of £56.6million had been raised, the Net Proceeds to Creo would have been £53.7million. Meaning that fees/expenses of £2.9million would have been payable by Creo out of gross proceeds, being a percentage of fees/expenses of 5.12% of amounts raised. In the event, a very healthy £51.9m was raised. Using the same fee structure of 5.12%, this means that fees of some £2,657,280 would have been payable. By far the largest chunk of these fees/expenses would have been payable to Cenkos. A great way to end the 2019 year. Just as Score Group/ Buchan 2 is a great way to start 2020 with a sole Adviser mandate for £120 million. Added to the upbeat statements given by conference sponsor Cenkos yesterday, things are beginning to look very encouraging again with some big fees already being scored under the aegis and return of the rainmaker Founding CEO. ALL IMO. DYOR. QP ps - haven't done the math but of course Cenkos would also have earned handsomely in the December IPO of MJ Hudson for £31.4million as well.
quepassa
11/2/2020
15:04
Number of companies listed on AIM is at 16 year low
albert zog
11/2/2020
14:26
Cenkos handed out a corporate leaflet at the Shares/Cenkos Growth and Innovation Forum in London this morning showing that they raised £493million on AIM in 2019 ranking them No.1 (Source LSE on AIM by NOMAD clients exc. REITS) and significantly ahead of all other peer-group competitors. Opening the conference, the senior Cenkos representative proclaimed openly that Cenkos had a "Fantastic pipeline of opportunities for 2020". Sounds encouraging, to say the least. ALL IMO. DYOR. QP
quepassa
10/2/2020
11:48
that would be nice but unlikely methinks.... my guess is circa 1% + which still means a fee of more than a million quid
quepassa
10/2/2020
11:00
Just an update on the Recommended Cash Offer for Score Group by Buchan 2 limited. It's gone UNCONDITIONAL, that means it's happening. Probable closing in March would seem likely. Cenkos Acting as sole Financial Adviser to the Buyer. Total consideration to be paid by Buchan for the acquisition is some £120 million. Whilst Cenkos fees not disclosed, this should be a very nice fat fee indeed for Cenkos as sole Adviser to Buchan. Any educated guesses please as to a likely fee as sole Financial Adviser to Buyer on this chunky £120million acquistion would be welcome. ALL IMO. DYOR. QP
quepassa
07/2/2020
08:50
CRL I think cwa1. The post man will be arriving soon so may be a chance to get in after the initial rush.
bazzer1000
07/2/2020
08:50
#CIP #CCSL #NAR #XAR #MTR #BAR #CNKS #AEP #PCF #CRL A right old mixed bag!
speedsgh
07/2/2020
07:48
If it's not too rude a question to ask, what are the others please?
cwa1
06/2/2020
23:47
They are in it - along with two others I hold; BAR and XAR.
value hound
06/2/2020
23:22
Rumour has it that Cenkos are one of the ten shares included in Simon Thompson's Bargain Shares 2020 portfolio in Investors Chronicle.
speedsgh
31/1/2020
04:36
I guess USF also have to raise an additional few million: "has been the victim of a fraud in relation to contracted construction payments totalling $6.9 million. " https://www.investegate.co.uk/us-solar-fund-plc--usf-/rns/detection-of-payment-fraud/202001301318464722B/
carcosa
Chat Pages: 149  148  147  146  145  144  143  142  141  140  139  138  Older
ADVFN Advertorial
Your Recent History
LSE
CNKS
Cenkos Sec..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20201001 01:56:41